glutathione disulfide has been researched along with Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berggren, KL; Bush, AI; Chen, J; Dodds, L; Dugas, B; Fox, J; Fox, JH; Lothian, A; McAllum, E; Miller, J; Roberts, B; Vargas, L; Volitakis, I | 1 |
| Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
| Agid, Y; Daniel, S; Dexter, DT; Javoy-Agid, F; Jenner, P; Lees, AJ; Marsden, CD; Sian, J | 1 |
3 other study(ies) available for glutathione disulfide and Huntington Disease
| Article | Year |
|---|---|
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease.
Topics: Animals; Animals, Newborn; Behavior, Animal; Corpus Striatum; Dietary Supplements; Disease Models, Animal; Energy Metabolism; Female; Gene Expression; Glutathione Disulfide; Humans; Huntington Disease; Iron Compounds; Mice; Mice, Transgenic; Motor Cortex; Neurons; Oxidative Stress; Phenotype; Rotarod Performance Test; Serotonin Plasma Membrane Transport Proteins | 2015 |
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia Diseases; Brain; Brain Diseases; Female; Glutathione; Glutathione Disulfide; Humans; Huntington Disease; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Supranuclear Palsy, Progressive | 1994 |